<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font22">the </span>
   <span class="font21">with </span>
   <span class="font20">respiratory </span>
   <span class="font19">for </span>
   <span class="font15">are </span>
   <span class="font14">patients </span>
   <span class="font13">viral </span>
   <span class="font13">infection </span>
   <span class="font13">HCT </span>
   <span class="font13">transplant </span>
   <span class="font13">RSV </span>
   <span class="font13">tract </span>
   <span class="font13">immunocompromised </span>
   <span class="font13">lower </span>
   <span class="font13">been </span>
   <span class="font13">ribavirin </span>
   <span class="font12">influenza </span>
   <span class="font12">virus </span>
   <span class="font12">cell </span>
   <span class="font12">not </span>
   <span class="font12">may </span>
   <span class="font12">{background </span>
   <span class="font12">associated </span>
   <span class="font12">have </span>
   <span class="font12">has </span>
   <span class="font12">hematopoietic </span>
   <span class="font12">infections </span>
   <span class="font12">recipients </span>
   <span class="font12">children </span>
   <span class="font12">disease </span>
   <span class="font12">The </span>
   <span class="font12">after </span>
   <span class="font12">human </span>
   <span class="font12">viruses </span>
   <span class="font12">detection </span>
   <span class="font12">from </span>
   <span class="font11">PIV </span>
   <span class="font11">clinical </span>
   <span class="font11">treatment </span>
   <span class="font11">margin </span>
   <span class="font11">was </span>
   <span class="font11">pediatric </span>
   <span class="font11">{border-style </span>
   <span class="font11">Infect </span>
   <span class="font11">px;} </span>
   <span class="font11">•Isolation </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Dis </span>
   <span class="font11">available </span>
   <span class="font11">can </span>
   <span class="font11">risk </span>
   <span class="font11">HMPV </span>
   <span class="font11">although </span>
   <span class="font11">care </span>
   <span class="font11">months </span>
   <span class="font11">most </span>
   <span class="font11">including </span>
   <span class="font11">should </span>
   <span class="font11">syncytial </span>
   <span class="font11">use </span>
   <span class="font11">were </span>
   <span class="font11">PIV- </span>
   <span class="font11">Transplant </span>
   <span class="font11">also </span>
   <span class="font11">oral </span>
   <span class="font11">recipients, </span>
   <span class="font11">severe </span>
   <span class="font11">therapy </span>
   <span class="font11">vaccination </span>
   <span class="font11">adults </span>
   <span class="font11">all </span>
   <span class="font11">but </span>
   <span class="font11">common </span>
   <span class="font11">detected </span>
   <span class="font11">more </span>
   <span class="font11">other </span>
   <span class="font11">patients. </span>
   <span class="font11">RSV, </span>
   <span class="font11">SOT </span>
   <span class="font11">adult </span>
   <span class="font11">against </span>
   <span class="font11">antiviral </span>
   <span class="font11">influenza, </span>
   <span class="font11">patients, </span>
   <span class="font11">recommended </span>
   <span class="font11">that </span>
   <span class="font10">aerosolized </span>
   <span class="font10">organ </span>
   <span class="font10">progression </span>
   <span class="font10">studies </span>
   <span class="font10">allogeneic </span>
   <span class="font10">control </span>
   <span class="font10">high </span>
   <span class="font10">mortality </span>
   <span class="font10">oseltamivir </span>
   <span class="font10">outcomes </span>
   <span class="font10">recipients. </span>
   <span class="font10">recipients: </span>
   <span class="font10">such </span>
   <span class="font10">than </span>
   <span class="font10">HMPV, </span>
   <span class="font10">HRV </span>
   <span class="font10">PIV, </span>
   <span class="font10">Respiratory </span>
   <span class="font10">data </span>
   <span class="font10">factors </span>
   <span class="font10">multicenter </span>
   <span class="font10">retrospective </span>
   <span class="font10">similar </span>
   <span class="font10">solid </span>
   <span class="font10">used </span>
   <span class="font10">vaccine </span>
   <span class="font10">who </span>
   <span class="font10">zanamivir </span>
   <span class="font10">Influenza </span>
   <span class="font10">Marrow </span>
   <span class="font10">during </span>
   <span class="font10">hospitalized </span>
   <span class="font10">less </span>
   <span class="font10">lung </span>
   <span class="font10">nasal </span>
   <span class="font10">parainfluenza </span>
   <span class="font10">potential </span>
   <span class="font10">prolonged </span>
   <span class="font10">px; </span>
   <span class="font10">those </span>
   <span class="font10">under </span>
   <span class="font10">{font-family </span>
   <span class="font10">Not </span>
   <span class="font10">Pediatric </span>
   <span class="font10">among </span>
   <span class="font10">antibody </span>
   <span class="font10">children. </span>
   <span class="font10">demonstrated </span>
   <span class="font10">efficacy </span>
   <span class="font10">font-size </span>
   <span class="font10">guidelines </span>
   <span class="font10">hematologic </span>
   <span class="font10">include </span>
   <span class="font10">intensive </span>
   <span class="font10">large </span>
   <span class="font10">molecular </span>
   <span class="font10">peramivir </span>
   <span class="font10">present </span>
   <span class="font10">procedures </span>
   <span class="font10">severely </span>
   <span class="font10">shedding </span>
   <span class="font10">significant </span>
   <span class="font10">stem </span>
   <span class="font10">study </span>
   <span class="font10">symptoms </span>
   <span class="font10">this </span>
   <span class="font10">young </span>
   <span class="font10">HCT, </span>
   <span class="font10">HCoV, </span>
   <span class="font10">Oncology </span>
   <span class="font10">United </span>
   <span class="font10">antibodies </span>
   <span class="font10">availability </span>
   <span class="font10">both </span>
   <span class="font10">chemotherapy </span>
   <span class="font10">community </span>
   <span class="font10">considered </span>
   <span class="font10">contact </span>
   <span class="font10">days </span>
   <span class="font10">decreased </span>
   <span class="font10">double; </span>
   <span class="font10">evaluated </span>
   <span class="font10">evidence </span>
   <span class="font10">fever </span>
   <span class="font10">hosts </span>
   <span class="font10">however, </span>
   <span class="font10">infection. </span>
   <span class="font10">likely </span>
   <span class="font10">oncology </span>
   <span class="font10">outbreaks </span>
   <span class="font10">sensitive </span>
   <span class="font10">strains </span>
   <span class="font10">upper </span>
   <span class="font10">virus, </span>
   <span class="font10">well </span>
   <span class="font10">•Infection </span>
   <span class="font10">•Supportive </span>
   <span class="font10">Blood </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Infections </span>
   <span class="font10">Infectious </span>
   <span class="font10">Limited </span>
   <span class="font10">Other </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">before </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bronchoalveolar </span>
   <span class="font10">caused </span>
   <span class="font10">diagnosis </span>
   <span class="font10">disease, </span>
   <span class="font10">drug </span>
   <span class="font10">effect </span>
   <span class="font10">even </span>
   <span class="font10">first </span>
   <span class="font10">generally </span>
   <span class="font10">high-dose </span>
   <span class="font10">hospital </span>
   <span class="font10">immune </span>
   <span class="font10">immunosuppressed </span>
   <span class="font10">inpatient </span>
   <span class="font10">its </span>
   <span class="font10">leukemia </span>
   <span class="font10">metapneumovirus </span>
   <span class="font10">need </span>
   <span class="font10">outbreak </span>
   <span class="font10">outpatient </span>
   <span class="font10">oxygen </span>
   <span class="font10">pneumonia </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">randomized </span>
   <span class="font10">rates </span>
   <span class="font10">receiving </span>
   <span class="font10">recent </span>
   <span class="font10">recommend </span>
   <span class="font10">regarding </span>
   <span class="font10">relatively </span>
   <span class="font10">remains </span>
   <span class="font10">resistance </span>
   <span class="font10">review </span>
   <span class="font10">rhinovirus </span>
   <span class="font10">solid; </span>
   <span class="font10">these </span>
   <span class="font10">time </span>
   <span class="font10">transmission </span>
   <span class="font10">transplant, </span>
   <span class="font10">trial </span>
   <span class="font10">trials </span>
   <span class="font10">virus; </span>
   <span class="font10">viruses, </span>
   <span class="font10">when </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">•Consider </span>
   <span class="font10">•Vaccination </span>
   <span class="font10">Available </span>
   <span class="font10">COVID- </span>
   <span class="font10">Clinical </span>
   <span class="font10">For </span>
   <span class="font10">HCoVs </span>
   <span class="font10">HRV, </span>
   <span class="font10">New </span>
   <span class="font10">Nosocomial </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">any </span>
   <span class="font10">because </span>
   <span class="font10">bold </span>
   <span class="font10">cancer </span>
   <span class="font10">centre </span>
   <span class="font10">close </span>
   <span class="font10">comparing </span>
   <span class="font10">concern </span>
   <span class="font10">consider </span>
   <span class="font10">courier; </span>
   <span class="font10">currently </span>
   <span class="font10">death. </span>
   <span class="font10">diagnostic </span>
   <span class="font10">em; </span>
   <span class="font10">epidemiology </span>
   <span class="font10">fatal </span>
   <span class="font10">followed </span>
   <span class="font10">had </span>
   <span class="font10">health </span>
   <span class="font10">healthy </span>
   <span class="font10">high-risk </span>
   <span class="font10">impact </span>
   <span class="font10">infected </span>
   <span class="font10">infection, </span>
   <span class="font10">inhaled </span>
   <span class="font10">intravenous </span>
   <span class="font10">levels </span>
   <span class="font10">malignancy </span>
   <span class="font10">monoclonal </span>
   <span class="font10">morbidity </span>
   <span class="font10">mortality. </span>
   <span class="font10">novel </span>
   <span class="font10">now </span>
   <span class="font10">often </span>
   <span class="font10">older </span>
   <span class="font10">one </span>
   <span class="font10">onset </span>
   <span class="font10">outcome </span>
   <span class="font10">particularly </span>
   <span class="font10">prevention </span>
   <span class="font10">prospective </span>
   <span class="font10">protein, </span>
   <span class="font10">pt;} </span>
   <span class="font10">quality </span>
   <span class="font10">reported </span>
   <span class="font10">require </span>
   <span class="font10">resource </span>
   <span class="font10">result </span>
   <span class="font10">results </span>
   <span class="font10">setting </span>
   <span class="font10">shedding, </span>
   <span class="font10">starting </span>
   <span class="font10">through </span>
   <span class="font10">undergoing </span>
   <span class="font10">vaccines </span>
   <span class="font10">via </span>
   <span class="font10">weeks </span>
   <span class="font10">within </span>
   <span class="font10">without </span>
   <span class="font10">younger </span>
  </p>
 </body>
</html>
